Search results for "Science"
Article
A New Paradigm in Process Development
Download this e-book for case studies and insights from Janssen, Roivant Sciences, and mAbxience.
Click here to download the e-book.
Article
Best Practices for Selecting a Top-Quality Cell Line
…ntrol (CMC) production cell line attributes,” agrees Jill Cai, vice-president of cell and protein sciences with WuXi Biologics.
Before scaling up to bioreactors, the productivity level for mon…
Article
A Successful First Year for Testa Center
… sector, business, and academia, and to boost the commercialization of new technologies in the life-sciences sector.
Click here to learn more.
Poster
Perfusion Media Development for Scalable Processes
Cell culture perfusion processes are considered optimal for a truly integrated continuous biomanufacturing pipeline. The nutrient-rich but balanced media should be designed to support very low cell-sp…
Article
The Value of Digital in Biopharma
Digital technology and data science can be leveraged to add flexibility and ease commercial scale-up.
Read the article
Article
What’s New in Upstream Technologies
By Amber Lowry
SCIENCE PHOTO - STOCK.ADOBE.COM
In recent months, a range of instruments and equipment have been introduced to advance upstream bioprocesses. The following is an …
Article
Leveraging Computational Models of Glycosylation for Biopharma QA
Close collaboration between academic and industrial groups is vital to ensuring glycosylation models are fit for deployment.
By Ioscani Jiménez del Val
Good Studio/S…
Article
Supply Chain Challenges for Single-Use Systems
BioPharm International spoke with Andrew Bulpin, head of Process Solutions at MilliporeSigma; Jeff Carter, strategic project leader at Cytiva; Eric Isberg, director of Life Sciences at Entegris; and H…
Article
Scaling Up Novel Therapies
“As interfacial science and data analytics evolve, however, within the next 10 years, process development work may routinely be done on a bench-top,” he says.
Some high-throughput tools a…
Article
Recent Advances in the Use of Exoglycosidases to Improve Structural Profiling of N-glycans from Biologic Drugs
Rudd is a visiting investigator, and Ian Walsh is an associate staff scientist; both are at Bioprocessing Technology Institute, Agency for Science, Technology and Research.
*To whom corresponde…